9-127854355-T-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong
The NM_001114753.3(ENG):āc.1A>Gā(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000000696 in 1,436,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 7.0e-7 ( 0 hom. )
Consequence
ENG
NM_001114753.3 start_lost
NM_001114753.3 start_lost
Scores
5
7
4
Clinical Significance
Conservation
PhyloP100: 3.63
Genes affected
ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 20 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_001114753.3 (ENG) was described as [Pathogenic] in ClinVar as 458346
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-127854355-T-C is Pathogenic according to our data. Variant chr9-127854355-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 407131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-127854355-T-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.1A>G | p.Met1? | start_lost | 1/15 | ENST00000373203.9 | |
ENG | NM_000118.4 | c.1A>G | p.Met1? | start_lost | 1/14 | ||
ENG | NM_001406715.1 | c.1A>G | p.Met1? | start_lost | 1/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ENG | ENST00000373203.9 | c.1A>G | p.Met1? | start_lost | 1/15 | 1 | NM_001114753.3 | P2 | |
ENG | ENST00000344849.4 | c.1A>G | p.Met1? | start_lost | 1/14 | 1 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 6.96e-7 AC: 1AN: 1436158Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 712250
GnomAD4 exome
AF:
AC:
1
AN:
1436158
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
712250
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2018 | PVS1+PM2+PP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Sep 29, 2022 | PVS1, PM2, PS4_moderate - |
not specified Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 17, 2017 | - - |
Hereditary hemorrhagic telangiectasia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 02, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 407131). Disruption of the initiator codon has been observed in individuals with hereditary haemorrhagic telangiectasia (PMID: 15517393, 16429404, 32573726; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the ENG mRNA. The next in-frame methionine is located at codon 183. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2020 | The p.M1? pathogenic mutation (also known as c.1A>G and p.M1V) is located in coding exon 1 of the ENG gene and results from an A to G substitution at nucleotide position 1. This alters the methionine residue at the initiation codon (ATG). This alteration has been identified in multiple individuals with hereditary hemorrhagic telangiectasia, most of whom meet Curaçao criteria (Letteboer TG et al. Hum Genet. 2005; 116(1-2):8-16; Lenato GM et al. Hum Mutat. 2006; 27(2):213-4; Gedge F et al. J Mol Diagn. 2007; 9(2):258-65; Curie A et al. J. Pediatr. 2007; 151(3):299-306; Calhoun AR et al. J Neurosurg Pediatr 2012; 9(6):654-9; Eli I et al. J Clin Neurosci 2018; 50:51-57; Gamboa NT et al. J Clin Neurosci 2018; 51:22-28). In addition to the clinical data presented in the literature, sequence variations that modify the initiation codon are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;.
Vest4
MutPred
Loss of stability (P = 0.0961);Loss of stability (P = 0.0961);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at